Bloomberg.com · Reporting
Aug 6, 2026
Vertical + Enterprise · Public company · Growth
Recursion
✓ VerifiedRecursion is one of the clearest examples of AI-native biotech at scale, using proprietary biological data and machine learning systems to accelerate drug discovery and platform partnerships.
Salt Lake City, USFounded 2013No public API trackedWeekly review target
Editorial intelligence brief
Editorial focus
Recursion's latest public model milestone is Boltz-2, which now sits alongside its broader Recursion OS 2.0 and Virtual Cell platform work.
Focus: Biotech foundation models and AI-driven drug discovery
Latest funding
Not tracked
No structured event
Tracked funding
Not tracked
No structured events
Latest valuation
Not tracked
No source-backed record
Latest revenue
Not tracked
Growth lifecycle position
Editorially verified updates
What changed
Recursion's latest public model milestone is Boltz-2, which now sits alongside its broader Recursion OS 2.0 and Virtual Cell platform work.
External coverage of Recursion
Selected by relevance, date and publisher; grouped by story. External reporting is not independently verified by the map. Article dates are publisher timestamps supplied by the discovery feed; quieter profiles may show coverage up to 90 days old.
Last checked Oct 18, 2026.
Bloomberg.com · Reporting
Aug 5, 2026
Source-backed financial history
Funding and financial history
Funding, valuation, revenue, and debt are kept separate so unlike measurements are never presented as one trend.
A structured financial history has not been completed for Recursion.
The profile will not manufacture a trend from incomplete or unsourced figures. Each amount must be dated, typed, and linked to public evidence first.
Product surface
Products and model families
Recent models
Boltz-2Recursion OS 2.0Virtual Cell
Products
Recursion OS 2.0Virtual CellBoltz-2
Open weights
No
API access
No
Review target
Weekly
Market position
Lifecycle and strategic signals
Research
Preview
Growth
Deployment
Growth: Public access & scaling
Focus
Biotech foundation models and AI-driven drug discovery
Signals
BiotechData moatPlatform
Taxonomy
Academic + NonprofitBiotechVertical + Enterprise
Competitive context
Isomorphic LabsAbsciSchrodinger
Infrastructure & distribution
Where Recursion sits in the AI stack
01
Model layer
3 tracked model families
02
Access layer
Application or managed product
03
Market layer
Vertical + Enterprise
Public product surface
Recursion OS 2.0Virtual CellBoltz-2
Stack signals
BiotechEnterpriseData moatPlatform
This section reflects publicly visible product and access signals. Undisclosed GPU, cloud, training, and data-center contracts are not inferred.
Evidence trail
Sources and corrections
Primary and public sources used to verify the structured company profile.
The Staticbreaker
Get the signal behind the week's AI changes.
The Staticbreaker turns launches, category shifts, and market noise into a concise editorial briefing.